Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Donnellan et al report on four patients with Parkinson's
disease in whom prescription of oxybutynin was associated with
worsening cognitive function.1 Cognitive impairment in Parkinson's disease is common. It has been suggested that when a
progressive decline in cognitive function in Parkinson's disease is
accompanied by visual hallucinations and fluctuating cognition a
secondary diagnosis of dementia with Lewy bodies is made.2 Dementia with Lewy bodies may present with neuropsychiatric features in
the absence of parkinsonism and, indeed, is probably the second most
common form of dementia in old age, only Alzheimer's disease being
more common.
Previous case series of patients with dementia with Lewy bodies have
shown exacerbations of confusion with orphenadrine (one case), little
or no effect on confusion with benzhexol, and no effect on fluctuating
confusion of withdrawing anticholinergic drugs in a 70 year old woman
with visual hallucinations.3 A prospective study of
dementia with Lewy bodies